INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list. Hundreds of ...

A group of compounding pharmacies has filed a lawsuit against the FDA, challenging the agency's decision to remove semaglutide — which is used to treat Type 2 diabetes and obesity — from the ...